Search research articles
Contact Us
Filters
Showing results (31-40 of 42) with videos related to
Page
of 5
Sort By:
The Journal of Clinical Investigation
|
June 1, 1982
Studies on a family with combined functional deficiencies of vitamin K-dependent coagulation factors
G H Goldsmith, R E Pence, O D Ratnoff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1990
Effect of tumor necrosis factor on the human fibrinolytic system
P Silverman, G H Goldsmith, T R Spitzer, et al.
Journal of Hematotherapy & Stem Cell Research
|
February 15, 2001
Mobilization of peripheral blood stem cells in high-risk breast cancer patients using G-CSF after standard dose docetaxel
D R Fleming, J Goldsmith, G H Goldsmith, et al.
The Journal of Clinical Investigation
|
June 1, 1989
Modulation of polymorphonuclear leukocyte microbicidal activity and oxidative metabolism by fibrinogen degradation products D and E
J W Kazura, J D Wenger, R A Salata, et al.
The Journal of Clinical Investigation
|
July 1, 1984
Bovine aortic endothelial cells elaborate an inhibitor of the generation of lipopolysaccharide-stimulated human blood monocyte procoagulant activity
L T Goodnough, M E Kleinhenz, G H Goldsmith, et al.
British Journal of Haematology
|
July 1, 1994
Inhibition of prothrombin activation by antiphospholipid antibodies and beta 2-glycoprotein 1
G H Goldsmith, S S Pierangeli, D W Branch, et al.
The Journal of Laboratory and Clinical Medicine
|
August 1, 1996
Studies on the interaction of placental anticoagulant protein I, beta 2 glycoprotein 1, and antiphospholipid antibodies in the prothrombinase reaction and in the solid phase anticardiolipin assays
S S Pierangeli, J Dean, G H Goldsmith, et al.
American Journal of Clinical Oncology
|
August 24, 2000
Phase I study of paclitaxel and day 1/day 8 gemcitabine in patients with solid malignancies
D R Fleming, S D Glisson, L Bhupalam, et al.
Blood
|
January 1, 1985
A monoclonal antibody that inhibits activation of human Hageman factor (factor XII)
E J Small, J A Katzmann, R P Tracy, et al.
The American Journal of Medicine
|
December 1, 1977
Activation of protein mediators of inflammation and evidence for endotoxemia in Borrelia recurrentis infection
R E Galloway, J Levin, T Butler, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 42) with videos related to
Sort By:
Page
of 5
The Journal of Clinical Investigation
|
June 1, 1982
Studies on a family with combined functional deficiencies of vitamin K-dependent coagulation factors
G H Goldsmith, R E Pence, O D Ratnoff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1990
Effect of tumor necrosis factor on the human fibrinolytic system
P Silverman, G H Goldsmith, T R Spitzer, et al.
Journal of Hematotherapy & Stem Cell Research
|
February 15, 2001
Mobilization of peripheral blood stem cells in high-risk breast cancer patients using G-CSF after standard dose docetaxel
D R Fleming, J Goldsmith, G H Goldsmith, et al.
The Journal of Clinical Investigation
|
June 1, 1989
Modulation of polymorphonuclear leukocyte microbicidal activity and oxidative metabolism by fibrinogen degradation products D and E
J W Kazura, J D Wenger, R A Salata, et al.
The Journal of Clinical Investigation
|
July 1, 1984
Bovine aortic endothelial cells elaborate an inhibitor of the generation of lipopolysaccharide-stimulated human blood monocyte procoagulant activity
L T Goodnough, M E Kleinhenz, G H Goldsmith, et al.
British Journal of Haematology
|
July 1, 1994
Inhibition of prothrombin activation by antiphospholipid antibodies and beta 2-glycoprotein 1
G H Goldsmith, S S Pierangeli, D W Branch, et al.
The Journal of Laboratory and Clinical Medicine
|
August 1, 1996
Studies on the interaction of placental anticoagulant protein I, beta 2 glycoprotein 1, and antiphospholipid antibodies in the prothrombinase reaction and in the solid phase anticardiolipin assays
S S Pierangeli, J Dean, G H Goldsmith, et al.
American Journal of Clinical Oncology
|
August 24, 2000
Phase I study of paclitaxel and day 1/day 8 gemcitabine in patients with solid malignancies
D R Fleming, S D Glisson, L Bhupalam, et al.
Blood
|
January 1, 1985
A monoclonal antibody that inhibits activation of human Hageman factor (factor XII)
E J Small, J A Katzmann, R P Tracy, et al.
The American Journal of Medicine
|
December 1, 1977
Activation of protein mediators of inflammation and evidence for endotoxemia in Borrelia recurrentis infection
R E Galloway, J Levin, T Butler, et al.
Page
of 5